The median investor spends just six minutes researching a stock before trading it, a recent study found. This can mean investors are taking on more risk than they're being compensated for. Before ...

Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal first ...